On June 13, 2024, PSM sent a letter to Congressmen Darrell Issa and Jerrold Nadler applauding the reintroduction of the Stopping Harmful Offers on Platforms by Screening Against Fake E-Commerce (SHOP SAFE) Act.
Read More
Fake Ozempic has been found in Brazil, the U.K., and the U.S. Eli Lilly warned the public about fake and compounded tirzepatide medicines. Additional domestic and international stories.
Read More
Florida still has not imported a single pill, patients seeking GLP-1 medicines at increased risk from phishing scams, the counterfeit medicine news from three other countries.
Read More
“Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products”
Read More
The FDA published its annual drug shortage report for 2023, CBP in Cincinnati seized multiple shipments of fake Ozempic, and international counterfeit medicine stories out of six different countries.
Read More
PSM submitted a letter to leaders in the New York State legislature opposing a legislative proposal (AB 7954) to setup a wholesale Canadian drug importation program. The bill died right before end of session.
Read More
PSM and ADAP Advocacy launched a campaign today about the dangers of medicine diversion criminals operating on gay dating apps such as Grindr. Learn more and report the crime on our campaign page.
Read More
The CAST Act introduced in the Senate. More lawsuits against copycat Wegovy sellers. Pill presses seized in multiple countries. Read about these and other stories in our weekly counterfeit medicine news roundup.
Read More
A Colorado board is considering setting a price limit on the medicine Stelara. This will have unintended consequences, undermining the safety of the supply chain for this medicine and limiting patient access. Learn more by reading our testimony.
Read More